Answers are grounded in this paper and cite their sources.
Triple-negative breast cancer (TNBC) is highly prevalent in West Africa and associated with poor prognosis and limited therapeutic options. Targeted quantitative metabolomic and lipidomic profiling was performed on pretreatment tumor biopsies from Senegalese women with TNBC ( n = 40) and hormone-dependent breast cancer (HDBC; n = 40). After exclusion of two PCA outliers, 39 samples per group were analyzed. Using the Biocrates MxP Quant 500 XL platform, 1019 analytes were assayed, and 655 metabolites were retained for statistical analysis. Sixty-nine metabolites differed significantly ( p < 0.01, fold change ≥ 1.2), including eight after FDR correction (q < 0.05). OPLS-DA showed robust group separation (Q 2 cum = 0.56; CV-ANOVA p < 2.62 × 10 −12 ). Machine learning classifiers achieved consistent discrimination (AUC ≥ 0.70), with Ridge regression performing best (AUC = 0.79). TNBC showed metabolic patterns consistent with increased glycolysis, fatty acid oxidation, glutaminolysis, and branched-chain amino acid catabolism, together with alterations potentially related to angiogenesis and extracellular matrix remodeling. Lipidomic differences included phosphatidylethanolamines, sphingolipids, and phosphatidylinositol species. Overall, tumor metabolomic and lipidomic profiling discriminated TNBC from HDBC and identified metabolic features associated with aggressive tumor biology in West African patients.
No takes yet. Share an insight, caveat, or question.
Barry et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: